cardiovascular benefits of glp 1 agonists GLP-1 Receptor in the Rehabilitation Patients with Heart Failure: Mechanisms, Clinical Evidence, and Future Perspectives The Cardiovascular Biology of Glucagon-like

While this signal reached weak statistical significance when stratifying the follow-up into early and late phases, such findings must be interpreted with caution

It is the most common cause of preventable blindness in the United States

NAS, nonalcoholic fatty liver activity score

Large-scale epidemiological studies have confirmed that metformin users have a significantly lower risk of developing various malignancies, including bladder, lung, prostate, pancreatic, head and neck, esophageal, liver, and colorectal cancers, compared to non-users [10]

Likewise, GIP receptor antagonists have been reported to induce weight loss in animal studies